The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions.
Unless we build bridges between our clinical work with patients and the public health mission that Virchow prescribed for us, we are doomed to futility in our efforts to help our patients.